{
  "retracted": false,
  "timestamp": 1567296000000,
  "updates": [
    {
      "timestamp": 1585245485443,
      "identifier": {
        "doi": "10.1016/j.ejca.2019.06.004"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ejca.2018.11.006"
  },
  "publisher": "Elsevier BV",
  "title": "Erratum to ‘Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)’ [Eur J Cancer 107 (January 2019) 46–52]"
}
